AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
8min chapter
What are the pros and cons of bispecific antibodies for multiple myeloma?
Multiple Myeloma Hub
Comparing CAR-T and Bi-specific Antibodies in Multiple Myeloma Treatment
Exploring the efficacy, patient inclusion, and sequencing considerations of CAR-T therapy versus bi-specific antibodies for multiple myeloma treatment. Discussion includes response longevity, off-the-shelf availability, and infection monitoring challenges of both treatments.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode